ArticleBMC research notes2025
Impact of HLD6-associated TUBB4A mutant proteins on cell morphogenesis.
Article in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The RhoG-Binding Domain of ELMO1 Rescues the PTENopathy-like Phenotype in Oligodendroglial FBD-102b Cells.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oligodendroglial cells are a type of glial cell in the central nervous system (CNS) that surround neuronal axons with a specialized cell membrane called the myelin sheath. Their physiological functions and their functional defects in pathological conditions have been well studied so far. However, the molecular mechanisms that control oligodendroglial cell differentiation and its destruction remain unclear. In oligodendroglial diseases such as congenital hypomyelinating leukodystrophies, differentiation often appears to be arrested at an immature stage. Here, for the first time, we report that hypomyelinating leukodystrophy type 6 (HLD6)-associated tubulin beta 4 A (TUBB4A) mutated proteins (6 types of missense mutations), but not the wild type one, disrupt the cell morphological changes with myelin sheath-like widespread membranes in FBD-102b cells, a mouse oligodendroglial model undergoing differentiation. Consistently, expression levels of oligodendroglial cell differentiation marker proteins and Akt kinase phosphorylation, a key signaling pathway promoting oligodendroglial differentiation and myelination, were reduced. Notably, mutated TUBB4A proteins failed to undergo the proper post-translational processing necessary for microtubule formation. Instead, these proteins localized aberrantly to intracellular organelle-like structures. These findings suggest that HLD6-asociated TUBB4A mutations lead to defective cell morphogenesis, providing novel insights into the pathological molecular mechanisms underlying differentiation arrest before myelination, at least at the molecular and cellular levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.